Evidence map›Paper›PMID 25568163›Full record

ReviewThe Journal of endocrinology2015

Lack of glucagon receptor signaling and its implications beyond glucose homeostasis.

Maureen J Charron, Patricia M Vuguin

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Characterization of Enlarged Tongues in Cloned Piglets.Current issues in molecular biology · 2023
    Article
  7. Article
  8. Chemical Compounds and Ambient Factors Affecting Pancreatic Alpha-Cells Mass and Function: What Evidence?International journal of environmental research and public health · 2022
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maureen J CharronDepartments of BiochemistryObstetrics and Gynecology and Women's HealthMedicineAlbert Einstein College of Medicine, 1300 Morris Park Avenue, F312, Bronx, New York 10461, USADepartment of PediatricsHofstra School of Medicine, Cohen Children's Medical Center, 1991 Marcus Avenue, Lake Success, New York 11402, USA Departments of BiochemistryObstetrics and Gynecology and Women's HealthMedicineAlbert Einstein College of Medicine, 1300 Morris Park Avenue, F312, Bronx, New York 10461, USADepartment of PediatricsHofstra School of Medicine, Cohen Children's Medical Center, 1991 Marcus Avenue, Lake Success, New York 11402, USA Departments of BiochemistryObstetrics and Gynecology and Women's HealthMedicineAlbert Einstein College of Medicine, 1300 Morris Park Avenue, F312, Bronx, New York 10461, USADepartment of PediatricsHofstra School of Medicine, Cohen Children's Medical Center, 1991 Marcus Avenue, Lake Success, New York 11402, USA pvuguin@nshs.edu maureen.charron@einstein.yu.edu.
Patricia M VuguinDepartments of BiochemistryObstetrics and Gynecology and Women's HealthMedicineAlbert Einstein College of Medicine, 1300 Morris Park Avenue, F312, Bronx, New York 10461, USADepartment of PediatricsHofstra School of Medicine, Cohen Children's Medical Center, 1991 Marcus Avenue, Lake Success, New York 11402, USA pvuguin@nshs.edu maureen.charron@einstein.yu.edu.
Albert Einstein College of Medicine · US

Funding

Regulation of Cardiac Glucose TransportersR01DK047425 · NIDDK · YESHIVA UNIVERSITY · PI CHARRON, MAUREEN J · 1995 to 2007
$2.3M
GLUT4 AND CARDIAC METABOLISM AND PHYSIOLOGYR01HL058119 · NHLBI · YESHIVA UNIVERSITY · PI CHARRON, MAUREEN J · 1997 to 2004
$1.5M
Nutrition, Early Development and Glucose MetabolismK08HD042172 · NICHD · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI VUGUIN, PATRICIA MYRIAM · 2003 to 2007
$634k
Molecular Basis of Insulin ResistanceR21DK081194 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CHARRON, MAUREEN J · 2008 to 2010
$525k
NHLBI NIH HHS HL58119NHLBI NIH HHS R01 HL058119NICHD NIH HHS K08 HD042172NICHD NIH HHS KO8 HD-042172NIDDK NIH HHS DK47425NIDDK NIH HHS R01 DK047425NIDDK NIH HHS R21 DK081194
6 · The paper itself

Abstract

Glucagon action is transduced by a G protein-coupled receptor located in liver, kidney, intestinal smooth muscle, brain, adipose tissue, heart, pancreatic β-cells, and placenta. Genetically modified animal models have provided important clues about the role of glucagon and its receptor (Gcgr) beyond glucose control. The PubMed database was searched for articles published between 1995 and 2014 using the key terms glucagon, glucagon receptor, signaling, and animal models. Lack of Gcgr signaling has been associated with: i) hypoglycemic pregnancies, altered placentation, poor fetal growth, and increased fetal-neonatal death; ii) pancreatic glucagon cell hyperplasia and hyperglucagonemia; iii) altered body composition, energy state, and protection from diet-induced obesity; iv) impaired hepatocyte survival; v) altered glucose, lipid, and hormonal milieu; vi) altered metabolic response to prolonged fasting and exercise; vii) reduced gastric emptying and increased intestinal length; viii) altered retinal function; and ix) prevention of the development of diabetes in insulin-deficient mice. Similar phenotypic findings were observed in the hepatocyte-specific deletion of Gcgr. Glucagon action has been involved in the modulation of sweet taste responsiveness, inotropic and chronotropic effects in the heart, satiety, glomerular filtration rate, secretion of insulin, cortisol, ghrelin, GH, glucagon, and somatostatin, and hypothalamic signaling to suppress hepatic glucose production. Glucagon (α) cells under certain conditions can transdifferentiate into insulin (β) cells. These findings suggest that glucagon signaling plays an important role in multiple organs. Thus, treatment options designed to block Gcgr activation in diabetics may have implications beyond glucose homeostasis.

Indexed as

AnimalsFemaleFetal DevelopmentGlucagonGlucoseHomeostasisHumansMiceModels, AnimalPancreasPregnancyPregnancy MaintenanceReceptors, GlucagonSignal TransductionGlucagonGlucoseReceptors, Glucagonglucagon cellspancreas

Identifiers

PMID25568163
PMCPMC12228988
OpenAlexW2109842629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.